These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 15269478)
21. Immunocytochemical detection of p53 in human gliomas. Bruner JM; Saya H; Moser RP Mod Pathol; 1991 Sep; 4(5):671-4. PubMed ID: 1758878 [TBL] [Abstract][Full Text] [Related]
22. J1-31 protein expression in astrocytes and astrocytomas. Shuangshoti S; Thorner PS; Ruangvejvorachai P; Saha B; Groshen S; Taylor CR; Malhotra S; Imam SA Neuropathology; 2009 Oct; 29(5):521-7. PubMed ID: 19019178 [TBL] [Abstract][Full Text] [Related]
23. [Histological classification of human gliomas: state of art and controversies]. Figarella-Branger D; Bouvier C Bull Cancer; 2005 Apr; 92(4):301-9. PubMed ID: 15888386 [TBL] [Abstract][Full Text] [Related]
25. Prognostic relevance of TP53 mutations, p53 protein, Ki-67 index and conventional histological grading in oligodendrogliomas. Hagel C; Krog B; Laas R; Stavrou DK J Exp Clin Cancer Res; 1999 Sep; 18(3):305-9. PubMed ID: 10606174 [TBL] [Abstract][Full Text] [Related]
26. Prognostic evaluation in supratentorial astrocytic tumors using p53, epidermal growth factor receptor, c-erbB-2 immunostaining. Hwang SL; Hong YR; Chai CY; Lin HJ; Howng SL Kaohsiung J Med Sci; 1998 Oct; 14(10):607-15. PubMed ID: 9819502 [TBL] [Abstract][Full Text] [Related]
27. Role of gemistocytes in astrocytoma progression. Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164 [TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical detection of p53 protein expression in various childhood astrocytoma subtypes: significance in tumor progression. Bodey B; Gröger AM; Bodey B; Siegel SE; Kaiser HE Anticancer Res; 1997; 17(2A):1187-94. PubMed ID: 9137469 [TBL] [Abstract][Full Text] [Related]
29. Expression of p53 in oligodendrogliomas. Kros JM; Godschalk JJ; Krishnadath KK; Van Eden CG J Pathol; 1993 Dec; 171(4):285-90. PubMed ID: 8158458 [TBL] [Abstract][Full Text] [Related]
30. Utility of in situ demonstration of 1p loss and p53 overexpression in pathologic diagnosis of oligodendroglial tumors. Hirose T; Ishizawa K; Shimada S Neuropathology; 2010 Dec; 30(6):586-96. PubMed ID: 20408960 [TBL] [Abstract][Full Text] [Related]
31. Platelet-derived growth factor expression correlates with tumor grade and proliferative activity in human oligodendrogliomas. Majumdar K; Radotra BD; Vasishta RK; Pathak A Surg Neurol; 2009 Jul; 72(1):54-60. PubMed ID: 19559929 [TBL] [Abstract][Full Text] [Related]
32. Telomerase activity and alterations in telomere length in human brain tumors. Hiraga S; Ohnishi T; Izumoto S; Miyahara E; Kanemura Y; Matsumura H; Arita N Cancer Res; 1998 May; 58(10):2117-25. PubMed ID: 9605755 [TBL] [Abstract][Full Text] [Related]
33. Expression of the p53 protein in a spectrum of astrocytic tumours. Ellison DW; Gatter KC; Steart PV; Lane DP; Weller RO J Pathol; 1992 Dec; 168(4):383-6. PubMed ID: 1336544 [TBL] [Abstract][Full Text] [Related]
34. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. Hartmann C; Meyer J; Balss J; Capper D; Mueller W; Christians A; Felsberg J; Wolter M; Mawrin C; Wick W; Weller M; Herold-Mende C; Unterberg A; Jeuken JW; Wesseling P; Reifenberger G; von Deimling A Acta Neuropathol; 2009 Oct; 118(4):469-74. PubMed ID: 19554337 [TBL] [Abstract][Full Text] [Related]
35. Caveolin-1 expression in diffuse gliomas: correlation with the proliferation index, epidermal growth factor receptor, p53, and 1p/19q status. Barresi V; Buttarelli FR; Vitarelli EE; Arcella A; Antonelli M; Giangaspero F Hum Pathol; 2009 Dec; 40(12):1738-46. PubMed ID: 19716156 [TBL] [Abstract][Full Text] [Related]
36. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas. Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555 [TBL] [Abstract][Full Text] [Related]
37. Comparative evaluation of p53-protein expression and the PCNA and Ki-67 proliferating cell indices in human astrocytomas. Kordek R; Biernat W; Debiec-Rychter M; Alwasiak J; Liberski PP Pathol Res Pract; 1996 Mar; 192(3):205-9. PubMed ID: 8739466 [TBL] [Abstract][Full Text] [Related]
38. Expression of Fas/APO-1 during the progression of astrocytomas. Tachibana O; Nakazawa H; Lampe J; Watanabe K; Kleihues P; Ohgaki H Cancer Res; 1995 Dec; 55(23):5528-30. PubMed ID: 7585627 [TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of Hsp-27 in astrocytic brain tumors: an immunohistochemical study. Assimakopoulou M; Sotiropoulou-Bonikou G; Maraziotis T; Varakis I Anticancer Res; 1997; 17(4A):2677-82. PubMed ID: 9252700 [TBL] [Abstract][Full Text] [Related]